CDER Review Overhaul Will Include Input From Foreign Reviewers
This article was originally published in The Tan Sheet
Executive Summary
FDA's Center for Drug Evaluation & Research will invite input from foreign drug regulators as part of a planned revamping of its NDA review process, CDER Director Janet Woodcock, MD, indicated at a seminar for center staff Sept. 15.